Cite
HARVARD Citation
Ascierto, P. et al. (2019). Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations. Journal for immunotherapy of cancer. 7 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ascierto, P. et al. (2019). Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations. Journal for immunotherapy of cancer. 7 (1), p. . [Online].